{"id":"eef2","name":"Elongation factor 2 (EEF2)","symbol":"EEF2","route":"/targets/eef2/","asOf":"2026-09-04","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3214","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167658","uniprot":"https://www.uniprot.org/uniprotkb/P13639/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P13639","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL1795108","open-targets":"https://platform.opentargets.org/target/ENSG00000167658","civic":"https://civicdb.org/genes/1938/summary","oncokb":"https://www.oncokb.org/gene/EEF2","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=EEF2","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=EEF2","depmap":"https://depmap.org/portal/gene/EEF2?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000167658-EEF2","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/1938","omim":"https://www.omim.org/entry/130610"}],"products":[{"id":"plitidepsin","name":"Plitidepsin","status":"established","modality":"Marine-derived cyclic depsipeptide (small molecule), intravenous","route":"/drugs/plitidepsin/"}],"trials":[{"id":"nct01102426","name":"Aplidin - Dexamethasone in Relapsed/Refractory Myeloma","nct":"NCT01102426","phase":"3","status":"completed"},{"id":"nct01876043","name":"Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial","nct":"NCT01876043","phase":"2"},{"id":"nct00229203","name":"A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma","nct":"NCT00229203","phase":"2","status":"completed"}],"pathways":[],"companies":["pharmamar"],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}